Vertex’s $4.9B bet; Layoffs at Novartis, Genentech, Sanofi; Star founders unveil new startups; and more

Ver­tex’s $4.9B bet; Lay­offs at No­var­tis, Genen­tech, Sanofi; Star founders un­veil new star­tups; and more Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here. There’s no bor­ing day in bio­phar­ma, and this was es­pe­cial­ly true this week with mul­ti­ple ex­clu­sives and scoops from the End­points team. See if you missed any­thing! Unlock this article instantly by becoming a free subscriber. You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.